Evidence map›Paper›PMID 28338057›Full record

ArticleScientific reports2017

The identification of ᴅ-tryptophan as a bioactive substance for postembryonic ovarian development in the planarian Dugesia ryukyuensis.

Kazuya Kobayashi, Takanobu Maezawa, Hiroyuki Tanaka, Hiroyuki Onuki, Yurie Horiguchi, Hiroshi Hirota, Tetsuo Ishida, Kihachiro Horiike, Yasutoshi Agata, Manabu Aoki and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Promising role of D-amino acids in irritable bowel syndrome.World journal of gastroenterology · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Kazuya KobayashiDepartment of Biology, Faculty of Agriculture and Life Science, Hirosaki University, 3 Bunkyo-cho, Hirosaki, Aomori 036-8561, Japan.
Takanobu MaezawaAdvanced Science Course, Department of Integrated Science and Technology, National Institute of Technology, Tsuyama College, 624-1 Numa, Tsuyama, Okayama 708-8509, Japan.
Hiroyuki TanakaDepartment of Biochemistry and Molecular Biology, Shiga University of Medical Science, Tsukiwa-cho, Seta, Ohtsu, Shiga 520-2192, Japan.
Hiroyuki OnukiRIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
Yurie HoriguchiCenter for Integrated Medical Research, School of Medicine, Keio University, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hiroshi HirotaRIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
Tetsuo IshidaDepartment of Biochemistry and Molecular Biology, Shiga University of Medical Science, Tsukiwa-cho, Seta, Ohtsu, Shiga 520-2192, Japan.
Kihachiro HoriikeDepartment of Biochemistry and Molecular Biology, Shiga University of Medical Science, Tsukiwa-cho, Seta, Ohtsu, Shiga 520-2192, Japan.
Yasutoshi AgataDepartment of Biochemistry and Molecular Biology, Shiga University of Medical Science, Tsukiwa-cho, Seta, Ohtsu, Shiga 520-2192, Japan.
Manabu AokiDepartment of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Kouhoku-ku, Yokohama 223-8522, Japan.
Motonori HoshiDepartment of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Kouhoku-ku, Yokohama 223-8522, Japan.
Midori MatsumotoDepartment of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Kouhoku-ku, Yokohama 223-8522, Japan.
Keio University · JPShiga University of Medical Science · JPRIKEN Center for Integrative Medical Sciences · JPHirosaki University · JPNational Institute of Technology, Tsuyama College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many metazoans start germ cell development during embryogenesis, while some metazoans possessing pluripotent stem cells undergo postembryonic germ cell development. The latter reproduce asexually but develop germ cells from pluripotent stem cells or dormant primordial germ cells when they reproduce sexually. Sexual induction of the planarian Dugesia ryukyuensis is an important model for postembryonic germ cell development. In this experimental system, hermaphroditic reproductive organs are differentiated in presumptive gonadal regions by the administration of a crude extract from sexual planarians to asexual ones. However, the substances involved in the first event during postembryonic germ cell development, i.e., ovarian development, remain unknown. Here, we aimed to identify a bioactive compound associated with postembryonic ovarian development. Bioassay-guided fractionation identified ʟ-tryptophan (Trp) on the basis of electrospray ionization-mass spectrometry, circular dichroism, and nuclear magnetic resonance spectroscopy. Originally masked by a large amount of ʟ-Trp, ᴅ-Trp was detected by reverse-phase high-performance liquid chromatography. The ovary-inducing activity of ᴅ-Trp was 500 times more potent than that of ʟ-Trp. This is the first report describing a role for an intrinsic ᴅ-amino acid in postembryonic germ cell development. Our findings provide a novel insight into the mechanisms of germ cell development regulated by low-molecular weight bioactive compounds.

Indexed as

OogenesisAnimalsFemaleHermaphroditic OrganismsMaleOvaryPlanariansTryptophanTryptophan

Identifiers

PMID28338057
PMCPMC5364533
OpenAlexW2603698463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.